In this paper we demonstrate that OC2 is involved in the “receptor conversion” from luminal/hormone-receptor positive tumors to basal/hormone-resistant/TNBC, thus contributing to tumor heterogeneity. The gene discussed is ONECUT2; the disease is neoplasm.